USING AI AND NEUROIMAGING
ADVANCED CLINICAL TRIALS AND THERAPIES
OPTIMIZED THERAPIES
OPTIMAL MEASURES
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
NEWS
https://www.qynapse.com/wp-content/uploads/2020/09/World-Alzheimer-Day_brain_website.png
703
1641
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-09-21 07:43:142020-09-21 07:43:14World Alzheimer's Day: Neuroimaging and artificial intelligence offer new opportunities for patients
https://www.qynapse.com/wp-content/uploads/2020/09/QyScore-data-MS_news-website-image_EN-v2.png
703
1577
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-09-16 16:33:552020-09-16 17:18:49Qynapse releases new data demonstrating the value of QyScore® for the clinical assessment of Multiple Sclerosis (MS)
https://www.qynapse.com/wp-content/uploads/2020/09/MSVirtual2020_logo.png
703
1640
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-09-07 10:22:432020-09-07 14:28:01Qynapse sponsors the 8th joint ACTRIMS-ECTRIMS meeting – MSVirtual2020
https://www.qynapse.com/wp-content/uploads/2020/08/Article-Covid-19_Qynapse_website2.png
547
1635
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-08-31 14:43:382020-08-31 14:43:39Qynapse supports the investigation of Covid-19 neurological manifestations
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
